The prevalence of viral hepatitis C in Latvia: A population-based study

Medicina

Volumn 47, Issue 10, 2011, Pages 532-535

  Tolmane, Ieva ^a,b   Rozentale, Baiba ^a,b   Keiss, Jazeps ^a   Arsa, Frida ^a   Brigis, Girts ^b   Zvaigzne, Aivars ^c  

^a State Agency Infectology Center of Latvia   (Latvia)

^b RIGA STRADINS UNIVERSITY   (Latvia)

^c UNIVERSITY OF LATVIA   (Latvia)

Author keywords

Hepatitis C; Population; Prevalence

Indexed keywords

EID: 84856680409     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina47100076     Document Type: Article

References (12)

1. Chen W, Wong T, Tomlinson G, Krahn M, Heathcote EJ. Prevalence and predictors of obesity among individuals with positive hepatitis C antibody in a tertiary referral clinic. J Hepatol 2008;49(5):711-7.
2. Vingre I, Rozentale B, Keiss J, Kuse V, Lazdina D, Markovs J, et al. The treatment guidelines of viral hepatitis C. 2nd ed. Riga: SA Infectology Center of Latvia; 2005.
3. Viksna L. Viral hepatitis C: clinical course, treatment, prognosis, prevention. Riga: SIA Nacionalais apgads; 2003. p. 26-36.
4. Heintges T, Wands JR. Hepatitis C virus: epidemiology and transmission. Hepatology 1997;26(3):521-6.
5. Martinez-Bauer E, Forns X, Armelles M, Planas R, Solà R, Vergara M, et al. Hospital admission is a relevant source of hepatitis C virus acquisition in Spain. J Hepatol 2008;48(1):20-7.
6. Lettmeier B, Muhlberger N, Schwarzer R, Sroczynski G, Wright D, Zeuzem S, et al. Market uptake of new antiviral drugs for the treatment of hepatitis C. J Hepatol 2008;49(4):528-536.
7. Hoffmann G, Berglund G, Elmsta S, Eriksson S, Verbaan H, Widell A, et al. Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged Swedish general urban population. Scand J Gastroenterol 2000;35:861-5.
8. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997;26:1006-11.
9. Abdel-Aziz F, Habib M, Mohamed MK, Abdel-Hamid M, Gamil F, Madkour S, et al. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 2000;32:111-5.
10. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144(10):705-14.
11. Dubois F, Desenclos JC, Mariotte N, Goudeau A. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. Hepatology 1997;25:1490-6.
12. Rozentale B. Hepatitis C in Latvia: facts and problems. [dissertation]. Riga: Riga Stradins University; 1995.